Hawkins NA - Search Results

1

A high seizure burden increases brain concentrations of specialized pro-resolving mediators in the Scn1a^+/- mouse model of Dravet syndrome.

Yip KL, Zhou C, Anderson LL, Hawkins NA, Kearney JA, Arnold JC. Yip KL, et al. Among authors: hawkins na. Prostaglandins Other Lipid Mediat. 2024 Dec 17;176:106943. doi: 10.1016/j.prostaglandins.2024.106943. Online ahead of print. Prostaglandins Other Lipid Mediat. 2024. PMID: 39701411 Free article.

2

The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a ^+/- Mouse Model of Dravet Syndrome.

Satpute Janve V, Anderson LL, Bahceci D, Hawkins NA, Kearney JA, Arnold JC. Satpute Janve V, et al. Among authors: hawkins na. Front Pharmacol. 2021 May 17;12:675128. doi: 10.3389/fphar.2021.675128. eCollection 2021. Front Pharmacol. 2021. PMID: 34079465 Free PMC article.

3

The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome.

Anderson LL, Doohan PT, Hawkins NA, Bahceci D, Garai S, Thakur GA, Kearney JA, Arnold JC. Anderson LL, et al. Among authors: hawkins na. Neuropharmacology. 2022 Mar 1;205:108897. doi: 10.1016/j.neuropharm.2021.108897. Epub 2021 Nov 22. Neuropharmacology. 2022. PMID: 34822817 Free PMC article.

4

Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome.

Anderson LL, Bahceci DA, Hawkins NA, Everett-Morgan D, Banister SD, Kearney JA, Arnold JC. Anderson LL, et al. Among authors: hawkins na. PLoS One. 2023 Jan 26;18(1):e0280842. doi: 10.1371/journal.pone.0280842. eCollection 2023. PLoS One. 2023. PMID: 36701411 Free PMC article.

5

A high seizure burden increases several prostaglandin species in the hippocampus of a Scn1a^+/- mouse model of Dravet syndrome.

Zhou C, Satpute V, Yip KL, Anderson LL, Hawkins N, Kearney J, Arnold JC. Zhou C, et al. Prostaglandins Other Lipid Mediat. 2024 Jun;172:106836. doi: 10.1016/j.prostaglandins.2024.106836. Epub 2024 Apr 9. Prostaglandins Other Lipid Mediat. 2024. PMID: 38599513

6

Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq.

Hawkins NA, Zachwieja NJ, Miller AR, Anderson LL, Kearney JA. Hawkins NA, et al. PLoS Genet. 2016 Oct 21;12(10):e1006398. doi: 10.1371/journal.pgen.1006398. eCollection 2016 Oct. PLoS Genet. 2016. PMID: 27768696 Free PMC article.

7

Unexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome.

Anderson LL, Hawkins NA, Thompson CH, Kearney JA, George AL Jr. Anderson LL, et al. Among authors: hawkins na. Sci Rep. 2017 May 10;7(1):1682. doi: 10.1038/s41598-017-01851-9. Sci Rep. 2017. PMID: 28490751 Free PMC article.

8

Screening of conventional anticonvulsants in a genetic mouse model of epilepsy.

Hawkins NA, Anderson LL, Gertler TS, Laux L, George AL Jr, Kearney JA. Hawkins NA, et al. Ann Clin Transl Neurol. 2017 Apr 26;4(5):326-339. doi: 10.1002/acn3.413. eCollection 2017 May. Ann Clin Transl Neurol. 2017. PMID: 28491900 Free PMC article.

9

Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome.

Calhoun JD, Hawkins NA, Zachwieja NJ, Kearney JA. Calhoun JD, et al. Among authors: hawkins na. Epilepsia. 2017 Aug;58(8):e111-e115. doi: 10.1111/epi.13811. Epub 2017 May 28. Epilepsia. 2017. PMID: 28556246 Free PMC article.

10

The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model.

Hawkins NA, Lewis M, Hammond RS, Doherty JJ, Kearney JA. Hawkins NA, et al. Sci Rep. 2017 Nov 10;7(1):15327. doi: 10.1038/s41598-017-15609-w. Sci Rep. 2017. PMID: 29127345 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters